Molecular Signature to Risk-Stratify Prostate Cancer of Intermediate Risk.

Published

Journal Article (Letter)

A new 30-gene signature has been described that separates prostate cancers of Gleason score ≤6 from those of Gleason score ≥8. It provides independent prognostic information for prostate cancers of intermediate risk (Gleason score of 7), which has the potential to stratify these patients into different risk groups. Clin Cancer Res; 23(1); 6-8. ©2016 AACRSee related article by Sinnott et al., p. 81.

Full Text

Published version (via Digital Object Identifier)
Pubmed Central version
Open Access Copy from Duke

Duke Authors

He, Yiping
Huang, Jiaoti

Cited Authors

Yin, Y; Zhang, Q; Zhang, H; He, Y; Huang, J

Published Date

January 2017

Published In

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research

Volume / Issue

23 / 1

Start / End Page

6 - 8

PubMed ID

27803045

Pubmed Central ID

27803045

International Standard Serial Number (ISSN)

1078-0432

Digital Object Identifier (DOI)

10.1158/1078-0432.CCR-16-2400

Scholars@Duke